BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 23056927)

  • 1. Effect of Inhibition of Angiotensin-Converting Enzyme and/or Neutral Endopeptidase on Neuropathy in High-Fat-Fed C57Bl/6J Mice.
    Coppey L; Lu B; Gerard C; Yorek MA
    J Obes; 2012; 2012():326806. PubMed ID: 23056927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vasopeptidase inhibitor ilepatril (AVE7688) prevents obesity- and diabetes-induced neuropathy in C57Bl/6J mice.
    Coppey L; Davidson E; Lu B; Gerard C; Yorek M
    Neuropharmacology; 2011; 60(2-3):259-66. PubMed ID: 20849865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of inhibition of angiotensin converting enzyme and/or neutral endopeptidase on vascular and neural complications in high fat fed/low dose streptozotocin-diabetic rats.
    Davidson EP; Coppey LJ; Holmes A; Yorek MA
    Eur J Pharmacol; 2012 Feb; 677(1-3):180-7. PubMed ID: 22198047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of the effect of inhibition of neutral endopeptidase on vascular and neural complications in streptozotocin-induced diabetic rats.
    Oltman CL; Davidson EP; Coppey LJ; Kleinschmidt TL; Dake B; Yorek MA
    Eur J Pharmacol; 2011 Jan; 650(2-3):556-62. PubMed ID: 21040718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Inhibition or Deletion of Neutral Endopeptidase on Neuropathic Endpoints in High Fat Fed/Low Dose Streptozotocin-Treated Mice.
    Yorek MS; Obrosov A; Lu B; Gerard C; Kardon RH; Yorek MA
    J Neuropathol Exp Neurol; 2016 Nov; 75(11):1072-1080. PubMed ID: 27634964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Treatment of Sprague Dawley Rats with AVE7688, Enalapril, or Candoxatril on Diet-Induced Obesity.
    Davidson EP; Coppey LJ; Dake B; Yorek MA
    J Obes; 2011; 2011():. PubMed ID: 20847891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of treatment of high fat fed/low dose streptozotocin-diabetic rats with Ilepatril on vascular and neural complications.
    Davidson EP; Coppey LJ; Holmes A; Dake B; Yorek MA
    Eur J Pharmacol; 2011 Oct; 668(3):497-506. PubMed ID: 21816138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiotensin I-converting enzyme-dependent and neutral endopeptidase-dependent generation and degradation of angiotensin II contrarily modulate noradrenaline release: implications for vasopeptidase-inhibitor therapy?
    Raasch W; Dominiak P; Dendorfer A
    J Hypertens; 2005 Aug; 23(8):1597-604. PubMed ID: 16003188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual inhibition of angiotensin converting enzyme and neutral endopeptidase produces effective blood pressure control in spontaneously hypertensive rats.
    Kostova E; Jovanoska E; Zafirov D; Jakovski K; Maleska V; Slaninka-Miceska M
    Bratisl Lek Listy; 2005; 106(12):407-11. PubMed ID: 16642666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early vs. late intervention of high fat/low dose streptozotocin treated C57Bl/6J mice with enalapril, α-lipoic acid, menhaden oil or their combination: Effect on diabetic neuropathy related endpoints.
    Yorek MS; Obrosov A; Shevalye H; Coppey LJ; Kardon RH; Yorek MA
    Neuropharmacology; 2017 Apr; 116():122-131. PubMed ID: 28025096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. COMPARATIVE EFFECT OF A HIGH FAT WITH OR WITHOUT HIGH LEVELS OF SUCROSE DIETS ON PERIPHERAL NEUROPATHY IN C57BL/6J MICE.
    Obrosov A; Coppey LJ; Shevalye H; Yorek MA
    J Diabet Complicat Ther; 2022; 1(1):. PubMed ID: 37332358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of SA7060, a novel dual inhibitor of neutral endopeptidase and angiotensin-converting enzyme, on deoxycorticosterone acetate-salt-induced hypertension in rats.
    Kuro T; Okahara A; Nose M; Ikuse T; Matsumura Y
    Biol Pharm Bull; 2000 Jul; 23(7):820-5. PubMed ID: 10919359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diet-induced obesity in Sprague-Dawley rats causes microvascular and neural dysfunction.
    Davidson EP; Coppey LJ; Calcutt NA; Oltman CL; Yorek MA
    Diabetes Metab Res Rev; 2010 May; 26(4):306-18. PubMed ID: 20503263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In-vitro and in-vivo inhibition of rat neutral endopeptidase and angiotensin converting enzyme with the vasopeptidase inhibitor gemopatrilat.
    Hubner RA; Kubota E; Casley DJ; Johnston CI; Burrell LM
    J Hypertens; 2001 May; 19(5):941-6. PubMed ID: 11393678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of combination therapy consisting of enalapril, α-lipoic acid, and menhaden oil on diabetic neuropathy in a high fat/low dose streptozotocin treated rat.
    Davidson EP; Holmes A; Coppey LJ; Yorek MA
    Eur J Pharmacol; 2015 Oct; 765():258-67. PubMed ID: 26291662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Omapatrilat, a dual angiotensin-converting enzyme and neutral endopeptidase inhibitor, prevents fatty streak deposit in apolipoprotein E-deficient mice.
    Arnal JF; Castano C; Maupas E; Mugniot A; Darblade B; Gourdy P; Michel JB; Bayard F
    Atherosclerosis; 2001 Apr; 155(2):291-5. PubMed ID: 11254898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of a vasopeptidase inhibitor with neutral endopeptidase and angiotensin-converting enzyme inhibitors on bradykinin metabolism in the rat coronary bed.
    Dumoulin MJ; Adam A; Rouleau JL; Lamontagne D
    J Cardiovasc Pharmacol; 2001 Apr; 37(4):359-66. PubMed ID: 11300648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The roles of streptozotocin neurotoxicity and neutral endopeptidase in murine experimental diabetic neuropathy.
    Davidson E; Coppey L; Lu B; Arballo V; Calcutt NA; Gerard C; Yorek M
    Exp Diabetes Res; 2009; 2009():431980. PubMed ID: 20148083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of angiotensin-converting enzyme (ACE), neutral endopeptidase (NEP) and dual ACE/NEP inhibition on blood pressure and resistance arteries of deoxycorticosterone acetate-salt hypertensive rats.
    Pu Q; Touyz RM; Schiffrin EL
    J Hypertens; 2002 May; 20(5):899-907. PubMed ID: 12011651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined inhibition of neutral endopeptidase with angiotensin converting enzyme or endothelin converting enzyme in experimental diabetes.
    Tikkanen I; Tikkanen T; Cao Z; Allen TJ; Davis BJ; Lassila M; Casley D; Johnston CI; Burrell LM; Cooper ME
    J Hypertens; 2002 Apr; 20(4):707-14. PubMed ID: 11910307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.